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ABSTRACT
Objective: The aim of the present study is to analyze four herbal dietary supplements containing genistein by liquid chromatography, quantitative 
nuclear magnetic resonance (qNMR), and diffusion ordered spectroscopy (DOSY) 1H NMR.
Methods: Quantification of the active ingredient, genistein, is carried out by high-performance liquid chromatography (HPLC) and qNMR. Two-
dimensional (2D) DOSY NMR also allows the qualitative analysis of the samples with the detection of active ingredient and excipients present in the 
formulations.
Results: The validated HPLC and qNMR methods showed that all four supplements contain genistein in different amounts, and 2D DOSY NMR provides 
a clear image of all ingredients in the formulations.
Conclusion: The use of the three techniques provides detailed information on each product and its contents, and all of them are currently used for the 
quality control of natural supplements by our laboratory.
Keywords: Genistein, Quantification, High-performance liquid chromatography, Quantitative nuclear magnetic resonance, Two-dimensional diffusion 
ordered spectroscopy.
INTRODUCTION
Polyphenols are a group of mainly natural, but also synthetic or 
semisynthetic, organic chemicals [1,2], which have been investigated for 
their protective effects on human health over the past two decades [3-6]. 
Studies have shown that, when incorporated into the diet, they limit the 
development of cancers, cardiovascular and neurodegenerative diseases, 
and others [7-13]. Polyphenols are subdivided into two large groups: 
Flavonoids and non-flavonoids [14]. Isoflavones are flavonoids in which 
the B ring is linked to the heterocyclic ring at the C3 position [15,16]. The 
most important isoflavones are genistein (Fig. 1), daidzein, and glycitein, 
which can occur in foods both in free and esterified forms [17].
Dietary supplements containing genistein have been investigated 
for their potential health effects in areas including prevention of 
breast, colon, and prostate cancers, cardiovascular disease, and 
postmenopausal ailments [18-22].
High-performance liquid chromatography (HPLC) has been used for 
decades for the quantification of chemical compounds as it offers a 
precise, accurate, reproducible, highly sensitive, quick, and automated 
analysis compared to other quantification methods (ultraviolet 
[UV], titration, etc.) [23]. Quantitative nuclear magnetic resonance 
(qNMR) has gained more attention recently as a structural tool 
and quantitative analytical technique because it provides several 
advantages, such as simple method development and quick and easy 
sample preparation [24,25]. Two-dimensional (2D) diffusion ordered 
spectroscopy (DOSY) 1H NMR is used for the accurate identification of the 
composition of drugs, dietary supplements, etc. The main advantage of 
DOSY NMR is to provide global information; it allows the fingerprinting 
of formulations and can be used to determine similarities or differences 
between samples [26]. The combination of these three techniques can 
give detailed information on the components of a complex sample.
The aim of this study was to analyze the genistein composition of 
commercially available capsules and our formulations of dietary 
supplements using simple, specific, accurate and precise methods, 
reversed-phase HPLC, and qNMR. The methods were validated with respect 
to specificity, linearity, precision, robustness, accuracy, limit of detection 
(LOD), and limit of quantification (LOQ) according to the International 
Conference of Harmonization guidelines [27]. 2D DOSY 1H NMR was also 
used for the quality assessment of the different formulations, especially on 
their excipient composition. To the best of our knowledge, it is the 1st time, 
the combination of all these techniques is used for the qualification and 
quantification of genistein in dietary supplements.
MATERIALS AND METHODS
Materials
Genistein capsules were purchased on the internet or provided as free 
samples and produced in our pharmaceutical technology laboratory. 
A list of the analyzed capsules is given in Table 1. All samples were 
stored in the dark at ambient temperature and analyzed before expiry 
dates. The genistein analytical standard ≥97% (standard for HPLC) 
and the benzoic acid (standard for qNMR) were purchased from 
Sigma-Aldrich (Louis, MO, USA). Deuterated solvent dimethyl sulfoxide 
(DMSO-d6, ˃99.96%), acetonitrile, and water for HPLC were also 
purchased from Sigma-Aldrich (Taufkirchen, Germany). Glacial acetic 
acid was purchased from Merck KGaA (Darmstadt, Germany).
Sample preparation and calculations
Chromatographic analysis
Both commercial and in-house supplements were analytically examined 
regarding their content. For HPLC analysis, the capsule content was 
weighed and dissolved in methanol resulting in genistein extraction 
(10.5 ppm). The volume of the sonicated extract was filtered through a 
0.45 µm filter and analyzed further for the assay.
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2020.v13i3.36094
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Where As and Astd are the peak response from the sample and standard 
solutions; mstd and ms are the weighted mass of genistein standard 
and genistein substance, respectively, and Pstd is the purity of genistein 
standard.
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Where As and Astd are the peak response from the sample and standard 
solutions; Cstd the standard solution concentration; Pstd the purity of 
genistein standard; MW the molecular weight of genistein; W the 
average capsule weight; and fdil the dilution factor of the standard 
solution.
NMR analysis
For the calculation of the assay of the supplements, as well as for 
DOSY experiments, 20 capsules were weighed and finely powdered. 
A portion of the powder equivalent to 5 mg and 5 mg of the internal 
standard were accurately weighed and transferred into a vial. The 
mixture was dissolved in 0.5 ml of DMSO-d6 using a vortex mixer. After 
centrifugation, the supernatant was transferred into an analytical NMR 
tube and the spectrum was obtained. The % purity was calculated using 


























Where Igen and Iben are the integral values of the signal that belongs to 
genistein and benzoic acid, respectively, Ngen and Nben the number of 
spins of genistein and benzoic acid; MWgen the molecular weight of 
genistein (270.24 g/mol); MWben the molecular weight of benzoic acid 
(122.12 g/mol); mgen and mben weighed mass of genistein and benzoic 
acid; and Pben the purity of benzoic acid (99.97%).
The amount of genistein per unit dose was calculated using equation 
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(4)
Where mpowder is the weighed mass of capsule powder sample taken for 
the assay and T is the average capsule weight. The significance of the 
other parameters is identical to the ones mentioned in equation (3).
Instrumentation
Chromatographic system and conditions
HPLC analysis was performed using an Agilent 1260 infinity series 
equipped with a multiple wavelength detector (Agilent Technologies 
Inc., Richardson, TX, USA). Chromatograms were integrated and 
analyzed using OpenLAB Chemstation (version M8301AA, Revision 
C.01.07 Agilent Technologies Inc., Richardson, TX, USA).
The analysis of genistein was performed using a column (Zorbax Eclipse 
RP C18 reversed-phase, 250 mm×4.6 mm I.D., 5 µm, Agilent, Santa 
Clara, CA, USA) maintained at 40°C. Mobile Phase A was water, mobile 
Phase B was acetonitrile, and mobile Phase C was glacial acetic acid. 
The mobile Phases A, B, and C were mixed at a ratio of 67.5:25.0:7.5 
(v/v). The flow rate was kept at 1.5 ml/min, injection volume was 10 µL 
and UV detection was carried out at 260 nm. The retention time of the 
genistein was 7.30 min.
1H and DOSY 1H NMR
1H-NMR and DOSY spectra were obtained using a Bruker Avance 
spectrometer at 400 MHz proton frequency (AV-III-HD, 400, 
Rheinstetten, Germany). The qNMR experiments were performed with 
the following optimized parameters: Pulse angle, 30°; pulse width, 
41.6 µs; data points 96152; and number of scans, 64; acquisition time 
(AQ), 3.999 s; spectral width, 12019.23 Hz. A line-broadening factor 
of 0.1 Hz was applied to FIDs before Fourier transformation, and the 
repetition delay was 60 s. All chemical shifts were reported in parts per 
million (ppm) relative to deuterated DMSO-d6 at 2.50 ppm. All spectra 
were automatically corrected for phase and baseline distortions 
using TOPSPIN (version 3.5pl5, Bruker Biospin, Spring, TX, USA). 
For statistical reasons, each measurement was repeated 6 times. The 
Fig. 1: Numbered chemical structure of genistein
Fig. 2: High-performance liquid chromatography chromatogram 
of the blank sample. Chromatogram obtained by Zorbax Eclipse 
RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile 
phase of water: acetonitrile: glacial acetic acid (67.5:25.0:7.5) and 
flow rate of 1.5 ml/min
Fig. 3: High-performance liquid chromatography chromatogram 
of the placebo sample (sample concentration=10.5 ppm). 
Chromatogram obtained by Zorbax Eclipse RP C18 reversed-
phase column (250 mm×4.6 mm, 5 μm), mobile phase of water: 
acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 
1.5 ml/min
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Table 1: Dietary supplements analyzed in this study
S. No Formulation name Batch number Product form
1 RGCC EXP2.2 Capsule
2 Swanson B225947 Capsule
3 Now 1937090 Capsule
4 Vital N/A Capsule
N/A: Not available, RGCC: Research Genetic Cancer Center
values of T1 relaxation time for targeted protons are listed below: For 
benzoic acid, δ 8.00 ppm (H-2 and H-6), T1=2.041 s; δ 7.60 ppm (H-4), 
T1=3.071 s; δ 7.50 ppm (H-3 & H-5), T1=2.255 s; and for genistein, 
δ 8.3 ppm (H-2), T1=2.217 s. For DOSY 1H NMR, stimulated echo 
bipolar gradient pulse experiments were used with a pulse delay of 
5 ms after each gradient, a pulse-field gradient length of 1 ms and a 
diffusion delay of 100 ms. Sequence parameters were adapted to have 
the intensity of the H2 NMR signal of genistein strongly decreased at 
95% of the full gradient length. All data were processed with TOPSPIN 
(version 3.5pl5, Bruker Biospin, Spring, TX, USA) software using the 
maximum entropy algorithm (MaxEnt). The processing parameters 
were 1024 points along the Laplace spectrum diffusion axis and 20000 
MaxEnt iterations. DOSY spectra are presented with chemical shift on 
the horizontal axis and diffusion coefficients expressed in µm2s−1 on 
the vertical axis.
RESULTS
Quantification of genistein by HPLC
Method validation
System suitability
The HPLC system was allowed to equilibrate for 30 min. A blank and a 
standard sample (10 replicates) were injected, and the chromatograms 
were recorded to evaluate the system suitability parameters such as % 
relative standard deviation (RSD) between replicate injections (<2%), 
theoretical plates (NLT 3000), and symmetry factor (0.8–1.5).
Specificity and selectivity
The specificity of the method was demonstrated by studying the effect 
of the excipients present in genistein formulations under optimum 
conditions. The blank, placebo, and genistein capsule samples were 
analyzed to examine the interference of blank and placebo with 
genistein peaks. No interference was observed. Furthermore, the well-
shaped peaks indicate the specificity of the method. The chromatograms 
of the blank, placebo, and genistein samples are presented in Figs. 2-4:
Linearity
The linearity of the method was determined by preparing standard 
solutions at different concentrations from 50% to 150% of the test 
concentration. The calibration curve is shown in Fig. 5. The least-square 
analysis method was applied for the calculation of the slope, intercept, 
and correlation coefficient.
Table 3: Validation parameters for the determination of genistein by quantitative nuclear magnetic resonance
qNMR parameters Results
Linearity δ*8.00 δ*7.60 δ*7.50
Equation y=0.2186x−0.0004 y=0.4339x−0.0004 y=0.4339x−0.0004
R2 0.9996 0.9996 0.9996
Concentration range (w/w) 0.20–1.96
Precision
Mean Pgen (%) 96.11 95.67 95.68
%RSD 0.59 0.52 0.60
Repeatability
Mean Pgen (%) 96.39 96.13 96.13
%RSD 0.74 0.69 0.71
Accuracy
%Recovery 98.13 97.86 97.90
%RSD 1.75 1.83 1.66
qNMR parameters Number of scans AQ (s) D1 (s) Protons (ppm)
Robustness
Mean Pgen (%) 96.07 95.74 95.58 96.34 95.97 96.01 96.18 96.00 95.90 97.42 96.37 96.89
%RSD 0.80 0.72 0.79 0.46 0.73 0.39 0.63 0.54 0.63 0 0 0
LOD (ppm) 0.175
LOQ (ppm) 0.526
LOD: Limit of detection, LOQ: Limit of quantification, RSD: Relative standard deviation, qNMR: Quantitative nuclear magnetic resonance, AQ: Acquisition time
Table 2: Validation parameters for the determination of 







Concentration range (ppm) 5.25–15.75













Flow rate (1.53 and 1.47 ml/min) 7.30 11619 0.677
7.31 11692 0.682
HPLC parameters Intraday Interday
Precision
Mean peak area 497.9 489.14
%RSD 0.19 0.19
Accuracy
Number of solutions analyzed 18




LOD: Limit of detection, LOQ: Limit of quantification, RSD: Relative standard 
deviation, HPLC: High-performance liquid chromatography
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Fig. 4: High-performance liquid chromatography chromatographs of Research Genetic Cancer Centre dietary supplement, Swanson 
dietary supplement, Now dietary supplement and Vital dietary supplement (sample concentration=10.5 ppm). All chromatograms 
obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile phase of water: acetonitrile: glacial acetic 
acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
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Robustness
Robustness was established by analyzing genistein under different 
experimental conditions, which entails making changes in parameters 
such as column temperature, column batch from the same manufacturer, 
and flow rate. All results were within the acceptance criteria (peak 
symmetry <1.5, plate count >3000) and no significant change in 
retention time.
Precision
Intraday and interday precision of the method was determined by 
analyzing ten test solutions at the same concentration (10.5 ppm) of 
genistein during the same day, under the same experimental conditions 
and on a different day, respectively. The RSD was calculated and is 
within the acceptable criteria (%RSD <2.0).
Accuracy and recovery tests
The accuracy was evaluated at three different concentrations equivalent 
to 50%, 100%, and 150% of the active ingredient, by adding a known 
amount of genistein standard to a sample with a pre-determined 
amount of genistein. Each concentration was evaluated in six replicates. 
The recovered amount of genistein, % recovery of each concentration, 
and %RSD of recovery were calculated to determine the accuracy.
LOD and LOQ
LOD and LOQ were calculated based on the standard deviation of the 
response and the slope of the calibration curve. This procedure is 
approved by the German Institute for Standardization and is regarded 
as a method, from which reliable and practically meaningful values 
can be obtained. The following formulas were used: LOD=3.3Sβ/α and 
LOQ=3LOD, where Sβ=standard deviation of response and α=slope of 
the calibration curve.
All the HPLC validation parameters are shown in Table 2:
Quantification of genistein by 1H NMR
Method validation
Specificity and selectivity
NMR spectroscopy provides very detailed structural information and, 
therefore, it possesses in principle, high specificity. qNMR is considered 
to be specific and selective the analyzed signal does not overlap with 
other components in the sample solution, including solvent and 
excipients in the formulation. Figs. 6 and 7 show 1H NMR spectra of 
internal calibrant solution, standard solution, placebo solution, and 
sample solution individually. It is evident that the signals at 8.32 for 
genistein and at 8.00, 7.60, and 7.50 ppm for benzoic acid are not 
overlapped by the solvent and excipients present. In addition, these 
signals are well separated from each other in standard and sample 
preparations.
Linearity
To check the linearity of the method, linearity tests were performed 
over a concentration range (w/w) for genistein per mg of benzoic acid. 
The results showed that the method had excellent linearity over these 
concentration ranges.
Precision and repeatability
The precision of the method was determined by measuring within a 
short time a 5 mg sample of genistein. Six samples were prepared and 
each sample was measured in triplicates. Repeatability was determined 
by measuring the 5 mg sample of genistein 6 times.
Robustness
The robustness of the method was estimated by varying four parameters 
independently: (1) Number of scans (32, 48, and 80), (2) AQ (3, 5, and 
6 s), (3) relaxation delay (30, 40, and 50 s), and (4) different analyte 
protons (6.39, and 6.23 ppm) chosen.
Accuracy and recovery tests
The accuracy of the method was estimated by analyzing nine mixtures 
with the known composition of genistein, genistein capsule powder, 
and benzoic acid and by measuring the mean recovery and RSD. 
Quantitative genistein was added to the capsules to investigate the 
recovery of genistein from capsules. The results indicate that the relative 
proportions of genistein and internal standard have no influence on the 
methods’ accuracy.
LOD and LOQ
LOD and LOQ were calculated in the same manner as in HPLC, using the 
same formulas.
All qNMR validation parameters are shown in Table 3.
The samples were analyzed in triplicates by HPLC and qNMR method, 
and the results are presented in Table 4. It is worth mentioning that two 
other isoflavones, glycitein and daidzein, were able to be identified and 
quantified, in comparison with their respective reference standards, 
in two supplements by HPLC. In particular, Now brand was found to 
contain 3.6 mg of daidzein and 2.6 mg glycitein and Vital 187.9 mg of 
daidzein. The chromatographs of all brands are shown in Figs. 8-12.

















Fig. 5: The relationship between the concentration of genistein 
(X-axis) and peak area (Y-axis)
Table 4: Genistein content (mg) in commercial capsules 
determined by high-performance liquid chromatography and 








RGCC 125 123.8 122.0 1.3
Swanson 125 122.2 119.9 1.6
Vital 250 248.1 246 1.5
Now 60 1.4 1.2 0.1
qNMR: Quantitative nuclear magnetic resonance, RSD: Relative standard 
deviation, HPLC: High-performance liquid chromatography, RGCC: Research 
Genetic Cancer Center
Table 5: Formulation ingredients
Ingredients RGCC Swanson Vital Now
Genistein + + + +
Daidzein − − + +
Glycitein − − − +
L-leucine − + − −
Calcium carbonate − − + −
Ascorbyl palmitate − − + −
Magnesium stearate − − − +
Rice flour − + + +
Corn starch + − − −
StarCap 1500 + − − −
Nuflow + − − −
RGCC: Research Genetic Cancer Center
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Fig. 6: (a) 1H nuclear magnetic resonance (NMR) spectrum of 5 mg benzoic acid in 0.5 ml dimethyl sulfoxide (DMSO-d6), (b) 1H NMR 




Fig. 7: (a) 1H nuclear magnetic resonance (NMR) spectrum of 5 mg genistein in 0.5 ml dimethyl sulfoxide (DMSO-d6). (b) 1H NMR spectrum 
of 5 mg Research Genetic Cancer Center capsules in 0.5 ml DMSO-d6. (c) 1H NMR spectrum of 5 mg Now capsules in 0.5 ml DMSO-d6. 
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Quality assessment by 2D DOSY 1H NMR
Four formulations of genistein were analyzed with 1H DOSY NMR, and 
their spectra along with their 1H spectra are presented in Figs. 13-16. 
The ingredients of each formulation are displayed in Table 5. Peaks 
at 3.3 and 2.5 ppm correspond to the signals of water and DMSO, 
respectively. All the peaks of the isoflavones present (genistein, 
glycitein, and daidzein) are lined up in the Research Genetic Cancer 
Center formulation. A deviation of one peak from the line is observed in 
the remaining three formulations due to a hydrogen exchange between 
the hydroxyl group in 7’ position and water. Although isoflavones 
glycitein and daidzein were identified and quantified in the Vital and 
Now supplements by HPLC, they could not be clearly observed in the 
DOSY spectra due to overlapping peaks with the peaks of genistein 
and similar molecular weights which result to similar diffusion 
Fig. 8: High-performance liquid chromatography chromatographs of genistein, glyciten and daidzein reference standards (sample 
concentration=10.5 ppm). All chromatograms obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), 
mobile phase of water:acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
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Fig. 9: High-performance liquid chromatography chromatograph of Research Genetic Cancer Centre dietary supplement (sample 
concentration=10.5 ppm). Chromatogram obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile 
phase of water:acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
Fig. 10: High-performance liquid chromatography chromatograph of Swanson dietary supplement (sample concentration=10.5 
ppm). Chromatogram obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile phase of water: 
acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
Fig. 11: High-performance liquid chromatography chromatograph of Now dietary supplement (sample concentration=10.5 ppm). 
Chromatogram obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile phase of water: 
acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
Fig. 12: High-performance liquid chromatography chromatograph of Vital dietary supplement (sample concentration=10.5 ppm). 
Chromatogram obtained by Zorbax Eclipse RP C18 reversed-phase column (250 mm×4.6 mm, 5 μm), mobile phase of water: 
acetonitrile:glacial acetic acid (67.5:25.0:7.5) and flow rate of 1.5 ml/min
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Fig. 13: 1H diffusion ordered spectroscopy nuclear magnetic resonance spectra of 5 mg Research Genetic Cancer Center formulation in 
0.5 ml of dimethyl sulfoxide (DMSO-d6) 
Fig. 14: 1H diffusion ordered spectroscopy nuclear magnetic resonance spectra of 5 mg Swanson formulation in 0.5 ml of dimethyl 
sulfoxide (DMSO-d6)
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Fig. 15: 1H diffusion ordered spectroscopy nuclear magnetic resonance spectra of 5 mg Vital formulation in 0.5 ml of dimethyl sulfoxide 
(DMSO-d6)
Fig. 16: 1H diffusion ordered spectroscopy nuclear magnetic resonance spectra of 5 mg Now formulation in 0.5 ml of dimethyl sulfoxide 
(DMSO-d6)
coefficients. Several excipients could be observed depending on the 
formulation. L-leucine peaks (LEUC) were observed in the Swanson 
formulation at 0.9, 1.0, and 1.2 ppm. Ascorbyl palmitate (ASCPAL) 
peaks were identified in the Vital formulation at 0.9, 1.1, 1.5, 2.3, and 
5.1 ppm. Magnesium stearate peaks (MGST) were present in the Now 
formulation at 0.89, 1.3, 1.5, and 2.13 ppm. The remaining excipients 
(rice flour, cornstarch, StarCap 1500, Nuflow) gave broad signals in the 
3–6 ppm region.
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DISCUSSION
The isoflavone content of four dietary supplements has been 
determined by HPLC, qNMR, and 2D1H DOSY NMR. The quantification 
of these compounds is generally carried out by HPLC or qNMR [29-
32]. However, the use of 2D 1H DOSY NMR allowed the detection of 
various components of these formulations in a single run. The results 
allow some conclusions to be made: The quantities of all isoflavones 
were calculated in Now brand, even though they are mentioned only as 
a total amount on the label and Vital brand was found to also contain 
daidzein and not only genistein as it is stated on the supplements’ label. 
Finally, all excipients and other ingredients were able to be identified 
by diffusion NMR.
CONCLUSION
Two methods (HPLC and qNMR) were developed and validated for 
genistein content determination in different supplements. The methods 
were proven accurate, precise, selective, and linear over the assessed 
concentration ranges. HPLC and quantitative NMR were used for the 
quantification of each formulation content in genistein. Diffusion 
NMR, which is considered as a strong analytical tool for the analysis 
of complex mixtures, was also used to assess the supplement quality. 
The combination of these techniques provided detailed information on 
each product and its contents and all of them are currently used for the 
quality control of natural supplements by our laboratory.
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